These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1660019)

  • 1. Serum factor from patients with cirrhosis and hepatocellular carcinoma enhances production of prostaglandin E2 by U937 cells.
    Iwamoto H; Sakamoto S; Nawata H
    Hepatology; 1991 Dec; 14(6):1123-8. PubMed ID: 1660019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
    Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
    Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma.
    Yokota M; Sakamoto S; Koga S; Ibayashi H
    Clin Exp Immunol; 1987 Feb; 67(2):335-42. PubMed ID: 3038436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
    Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
    Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Tsukamoto T; Kawai S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Nishiguchi S; Kinoshita H
    Hepatogastroenterology; 2003; 50(50):497-9. PubMed ID: 12749255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
    Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
    Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
    Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
    Chen XP; Wu ZD; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.